Rx for FDA Inaction: Competition
Executive Summary
The FDA won't reform itself because it is a monopoly, argues Peter Barton Hutt. His solution: competition: if either the European Medicines Evaluation Agency or the UK's Medicines Control Agency approves a drug, the FDA would have 90 days to veto a sponsor's application for approval--any veto having to be accompanied by a specific clinical rationale.